Citadel Advisors
AKAO

Citadel Advisors’s Achaogen Inc AKAO Stock Holding History

Citadel Advisors’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-40,659
Closed -$18K – 10329
2019
Q1 		$18K Sell
40,659
-1,039
-2% -$1.09K ﹤0.01% 9084
2018
Q4 		$51K Sell
41,698
-46,845
-53% -$125K ﹤0.01% 8487
2018
Q3 		$354K Sell
88,543
-63,771
-42% -$385K ﹤0.01% 7305
2018
Q2 		$1.32M Buy
+152,314
New +$1.86M ﹤0.01% 4756
2018
Q1 		– Sell
-32,005
Closed -$363K – 9094
2017
Q4 		$344K Sell
32,005
-704,084
-96% -$8.84M ﹤0.01% 6227
2017
Q3 		$11.7M Sell
736,089
-130,494
-15% -$2.48M 0.01% 1464
2017
Q2 		$18.8M Buy
866,583
+584,182
+207% +$13.3M 0.02% 1030
2017
Q1 		$7.13M Buy
282,401
+229,016
+429% +$4.7M 0.01% 1691
2016
Q4 		$695K Buy
+53,385
New +$366K ﹤0.01% 4391
2015
Q2 		– Sell
-3,664
Closed -$36K – 9291
2015
Q1 		$36K Buy
+3,664
New +$41.3K ﹤0.01% 7600

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Citadel Advisors's AKAO Position: Q2 2019 in Review

Citadel Advisors sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 40,659 shares — an estimated $18K sold.

Citadel Advisors first reported a position in AKAO in Q1 2015 and held it in 10 quarters. The position peaked at $18.8M in Q2 2017. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.

  • Citadel Advisors reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
  • Citadel Advisors sold 40,659 Achaogen Inc shares in Q2 2019, an estimated $18K.
  • Citadel Advisors first reported a position in Achaogen Inc in Q1 2015 and held it in 10 quarters.
  • Citadel Advisors's Achaogen Inc position peaked at $18.8M in Q2 2017.
  • 8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.